"Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients." by Leila Mureebe

Selected Works of Richard Coats, MD, FACS

Follow Contact

Article

Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients.

Surgery (2004)

Leila Mureebe, University of Missouri
Richard D. Coats, University of Missouri
W. Ray Silliman, University of Missouri
Thomas A. Shuster, University of Missouri
W. Kirt Nichols, University of Missouri
Donald Silver, University of Missouri

Link

Disciplines

Medicine and Health Sciences,
Surgery,
Epidemiology and
Internal Medicine

Publication Date

October 1, 2004

DOI

10.1016/J.SURG.2004.07.004

Citation Information

Leila Mureebe, Richard D. Coats, W. Ray Silliman, Thomas A. Shuster, et al.. "Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients." Surgery Vol. 136 Iss. 4 (2004) p. 848 - 853
Available at: http://works.bepress.com/richard-coats/4/